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CASE REPORT
A rare association of Takotsubo cardiomyopathy with neuroleptic malignant
syndrome
Waqas Ullah a, Muhammad Arslan Cheema b, Ammar Ashfaqa, Maryam Mukhtar c, Zain Ali a,
Mamoon Ur Rashid d and Vincent Figueredoe
aInternal Medicine, Abington, Jefferson Health, Abington, PA, USA; bDepartment of Internal Medicine, Abington, Jefferson Health,
Abington, PA, USA; cRawal Pindi Institute of Cardiology, Rawalpindi, Pakistan; dAdventHealth, Orlando, FL, USA; eSaint Mary Medical
Center, Philadelphia, PA, USA
ABSTRACT
Neuroleptic malignant syndrome is a potentially fatal neurological condition secondary to
antipsychotic medication. It is characterized by distinctive clinical findings and autonomic
disturbances. NMS has not been associated with Takotsubo cardiomyopathy (TCM).
TCM is an abnormal response to physiological stressors resulting from the autonomic
abnormalities which at times can mimic myocardial infarction (MI). We present a unique case
of a 54-year-old female with bipolar disease presenting with lithium and haloperidol-induced
NMS complicated by TCM. The purpose of this case is to make clinicians aware of this rare
association.
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NMS is an uncommon condition, usually associated
with hyperthermia and muscle rigidity in the presence
of raised creatine phosphokinase (CPK) levels. Patients
also have several autonomic symptoms, such as tachy-
cardia, increased blood pressure, urinary retention,
hypersalivation, and sweating. NMS dysautonomia has
not been associated with left ventricular systolic dys-
function (LVSD), such as TCM. We have presented
a rare association of Takotsubo cardiomyopathy with
the neuroleptic malignant syndrome and have high-
lighted the importance of medication adjustments dur-
ing the management of NMS in such conditions.
2. Case presentation
A 54-year-old woman with a past medical history of
anxiety, hypothyroidism and bipolar disorder pre-
sented to the emergency room (ER) for evaluation
of a change in mental status for 2 days. Her bipolar
disorder had been well controlled for many years on
lithium and trifluoperazine. However, she was
recently started on perphenazine due to a shortage
of trifluoperazine. She was noted to be extremely
agitated and dehydrated in the ER.
On arrival, she was afebrile with normal blood
pressure and slightly tachycardic (90 bpm). For the
agitation, she received two doses of Haldol 5 mg.
Subsequently, she became catatonic with diffuse mus-
cle rigidity. On examination, she was oriented to
person but not to place, time or events.
Her blood pressure rose to 170/85 mmHg, her
heart rate increased (122/minute) and her tempera-
ture rose to 105 F. Her cardiac, chest and abdominal
examinations were unremarkable.
After admission, in the general ward, the patient
complained of chest pain and ST-segment elevation
was noted on EKG. (Figure 1) A rapid response was
called. The patient was ultimately intubated and
shifted to the cardiac unit where her coronary angio-
graphy was done, which came out normal. (Figure 2).
However, echocardiography showed her left ventricu-
lar ejection fraction (LVEF) to be 20–25%.
Echocardiography showed good movement of the
basal wall and severe hypokinesis of the rest of the
walls consistent with Takotsubo cardiomyopathy.
(Figure 3) She required the insertion of IABP and
heparin infusion. Over time her blood pressure
improved and IABP was removed subsequently.
During her second day in CCU, she was found to
have left upper extremity swelling which required
evaluation with doppler, which was suggestive of
subclavian vein thrombosis. Heparin was stopped
due to the suspicion of heparin-induced thrombocy-
topenia (HIT). HIT antibodies and serotonin release
assay (SRA) were sent and she was started on arga-
troban. She became hypoxic for which a computed
tomography with pulmonary embolism (CTPE) pro-
tocol was done showing pulmonary embolism.
(Figure 4) HIT assay came back negative. The initial
CT scan of the head was unremarkable. Therefore, an
MRI brain was done which showed multiple infarcts.
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She ultimately tolerated extubation but was nonverbal
and bedridden due to multiple infarcts.
Blood work was significant for elevated creatinine
levels of 1.32 mg/dL, blood urea nitrogen of 10 mg/
dL and creatinine kinase levels of 9529 U/L.
Complete blood count and liver function tests were
unremarkable. During the rapid response, EKG
showed ST-segment elevation in precordial leads, an
x-ray showed bilateral infiltrates, BNP was 747 pg/ml,
and a creatine kinase level of 9876 U/L. Troponins
elevated to 9.05 ng/ml. Right heart catheterization
showed a wedge pressure of 23 mmHg, a mean pul-
monary artery pressure of 36, and a cardiac output of
2.3 L/min. A left heart catheterization showed normal
coronaries but LVEF of 20–25% by left ventriculo-
graphy. Subsequent brain MRI showed acute infarc-
tion in the subcortical white matter of the high right
parietal lobe, and possible subcentimeter bifrontal
foci of acute infarction.
Because of fever and a change in mental status,
meningitis/encephalitis was high on the differential.
Lumbar puncture (LP) was unsuccessful as the patient
was extremely agitated. She was started on vancomycin,
Figure 1. EKG showing ST segment elevation.
Figure 2. Coronary artery angiography showing the normal
flow.
Figure 3. Echocardiography showing decreased wall motion in systole.
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ceftriaxone, ampicillin, and acyclovir. She was initially
admitted to the progressive care unit (PCU) with
a working diagnosis of CNS infection versus neuroleptic
malignant syndrome. She was also started on dantro-
lene (skeletal muscle relaxant) and bromocriptine
(dopamine agonist) which were later discontinued.
Her repeat EKG showed a resolution of ST elevation.
(Figure 5) The patient was ultimately discharged to
a rehabilitation center after a prolonged hospitalization.
A 6 month follow up revealed an uneventful recovery,
and the patient had no further episodes of Takotsubo
cardiomyopathy.
3. Discussion
NMS is seen in 0.02 to 3% of patients taking neuroleptic
medications [1,2]. It has been described in patients aged
9 months to 78 years [1]. Several antiemetics and neu-
roleptic agents can precipitate NMS; most common are
the high-potency antipsychotic medications like fluphe-
nazine and haloperidol [2]. Interestingly lithium by
itself rarely causes NMS, but concomitant with other
psychotropic drugs, especially the above mentioned
higher-potency agents can precipitate NMS. Medical
illnesses, like infections and stress from trauma and
surgery, can also trigger NMS in the setting of lithium
use [1]. Our patient had a long-standing history of
lithium use and received haloperidol for agitation.
This combination incited the event of life-threatening
hyperthermia, catatonia and laboratory findings consis-
tent with NMS.
The pathogenesis of NMS can be explained by the
class of medications associated with NMS, most of
which are the anti-dopaminergic agents. Hyperthermia,
dysautonomia, and dystonia in NMS are due to the
blockade of central dopamine receptors in the hypotha-
lamus [3]. Catatonia and rigidity are due to inhibition of
the nigrostriatal dopaminergic pathways [3]. Another
proposed mechanism for rigidity and unregulated vaso-
motor activity (labile blood pressure and tachycardia) in
NMS is the increase in the sympathetic drive [4].
Similarly, Becker et al first reported its association with
myocardial infarction due to high catecholamine and
sympathetic hyperactivity [5]. Interestingly, TCM has
also been shown to be linked to endothelial dysfunction
and estrogen deficiency, which explains why it is more
common in postmenopausal women. Findings from
recently published data suggest that patients with TCM
had an underlying endothelial dysfunction. Both
increased sympathetic drive and endothelial dysfunction
Figure 4. CTPE showing pulmonary artery embolism.
Figure 5. EKG showing resolution of ST segment elevation.
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during menopause are due to decreased estrogen levels,
thus increasing the risk of TCM in menopausal
women [6].
It is unclear how NMS causes TCM as the litera-
ture is very scarce and only one case has been
reported so far by Oomura et al [7]. But the possible
mechanism for TCM in NMS is hypothesized to be
the autonomic dysregulation in NMS.
TCM is also called stress cardiomyopathy or apical
ballooning syndrome due to its association with stress
and characteristic findings on echocardiography,
respectively. It has been reported with a variety of
stressors and is characterized by reversible LVSD,
EKG findings similar to MI, but clean coronary arteries
on angiography [8,9]. The proposed mechanism is the
excess of circulatory catecholamine, coronary artery
spasm, and microvascular dysfunction [10].
Approximately 44% of patients can have ST-segment
elevation, mostly in the anterior precordial leads, which
cannot be distinguished from ST-elevation MI [11].
Approximately 10% of TCM patients can complicate
into cardiogenic shock [9]. Our patient’s high catecho-
lamine state potentially caused TCM with ST-elevation
and the resulting cardiogenic shock.
Thus, TCM can be regarded as one potential com-
plication of NMS related to autonomic dysfunction [7].
Other features of NMS are hyperthermia and rigid-
ity which occur along with mental status changes [12].
This NMS tetrad typically lasts 1–3 days and present
in about 97 to 100% of patients [12]. Diagnosis of NMS
is made by these symptoms in the setting of associated
medication use and raised CK levels. Based on clinical
and laboratory findings, an international multispecialty
consensus group released diagnostic criteria for the
diagnosis of NMS in 2011 [13]. These criteria also
emphasize the exclusion of alternative diagnoses before
labeling someone with NMS, with each item given
a priority score based on its importance in NMS diag-
nosis [13]. TCM, on the other hand, requires the pre-
sence of a stressor and characteristic echocardiographic
findings of LVSD with apical akinesia for diagnosis. It
is important to rule out CAD by angiography before
labeling someone with TCM.
NMS management includes dantrolene, which
decreases CK levels and body temperature [14].
Bromocriptine has also been found to hasten clinical
response [15]. All patients should be given supportive
care with intravenous fluids and electrolytes. Renal
function should be monitored and managed accord-
ingly. Complete recovery is reduced by 6 days with
dantrolene and 5 days with bromocriptine if given in
addition to supportive care alone [15]. There is evi-
dence of reduced mortality of about 8.6% with dantro-
lene and 7.8% with bromocriptine, compared with
supportive care (21%) [16]. TCM in NMS is treated
just like any other TCM, where the management of the
responsible stressor is of paramount importance [8].
Treatment of TCM should be individualized depending
upon the TCM related complications such as for
LVSD. Anticoagulation is sometimes needed for asso-
ciated thrombosis in the ventricle [8]. Patients with
cardiogenic shock usually recover with transient use
of intra-aortic balloon pump as in our case.
Patients with TCM usually have a good prognosis
and the heart function returns to normal over the
course of a few months. However, the risk of severe
complications in the hospital is similar to patients
with acute MI [9]. NMS takes about two weeks to
normalize and the slow and careful resumption of the
neuroleptic agents should be considered. However, it
can have devastating complications such as wide-
spread thrombosis as occurred in our case where
the patient had multiple ischemic infarcts, venous
thrombosis, and pulmonary embolism.
4. Conclusion
NMS associated TCM should be suspected in patients
presenting with rigidity and fever and the appearance
of an acute MI. It is important to avoid dantrolene in
such patients as it can worsen the cardiomyopathy.
TCM is reversible if the NMS is managed appropri-
ately. NMS be complicated by widespread thrombosis
and hence should be managed promptly.
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